Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.
Financial Statements
- Click here to download Edwards Lifesciences Corp's Income Statement
- Click here to download Edwards Lifesciences Corp's Balance Sheet
- Click here to download Edwards Lifesciences Corp's Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Michael Mussallem
Key Statistics
- Stock Price: $113.21
- Dividend Yield: 0%
- Market Capitalization: $70,760,176,737
- Shares Outstanding: 623,327,843
- Number of Employees: 14,900
- Trailing 12-Month EPS: $2.31
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2021-10-27
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $113.21
- 52-week high: $123.27
- 52-week low: $70.92
- 200-day moving average: $102.03
- 50-day moving average: $118.3
Performance
- 1-Month Price Return: -2.5%
- 3-Month Price Return: 9.6%
- 6-Month Price Return: 37.7%
- 1-Year Price Return: 45.0%
- 2-Year Price Return: 56.7%
- 5-Year Price Return: 185.6%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast